Evidence map›Paper›PMID 41993663›Full record

ReviewTaiwan journal of ophthalmology

Dacryoendoscopy: Historical development, philosophical foundation, and clinical perspective.

Toru Suzuki, Tomoyuki Kamao, Jutaro Nakamura, Akemi Iwasaki, Nozomi Matsumura

Abstract readReview
In one paragraph

Review in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Toru SuzukiSuzuki Eye Clinic, Fukuoka, Japan.
Tomoyuki KamaoDepartment of Ophthalmology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
Jutaro NakamuraDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Akemi IwasakiOtaki Eye Clinic, Chiba, Japan.
Nozomi MatsumuraDepartment of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dacryoendoscopy is valuable for managing epiphora, enabling direct visualization of the lacrimal outflow system. Notably, dacryoendoscopy enhances diagnostic precision and facilitates minimally invasive treatment. Over the past three decades, its evolution has fostered a deeper understanding of endoluminal pathology, refined recanalization techniques, and expanded therapeutic indications across age groups. Importantly, dacryoendoscopy represents not only technical refinement but also a conceptual shift - from blind intervention to anatomy-based diagnosis and management. This shift reflects a deeper surgical philosophy, that visualization must precede intervention, and that humility toward unseen structures is crucial for true minimally invasive practice. This narrative review explores the device design philosophy, terminology, and clinical use of dacryoendoscopy, focusing on the Bent group's contributions and the emergence of conservative minimally invasive lacrimal surgery, which emphasizes mucosal preservation and is specifically suited for pediatric cases. The Bent probe endoscopes, originating in Japan, have become the most widely used devices in Asia. Moreover, false passage was illustrated in relation to the duct lumen remnant within fibrous blockage, and key techniques, including sheath-guided endoscopic probing and sheath-guided intubation, were reviewed. Regardless of these advances, challenges such as long-term deterioration of surgical outcomes and the distant goal of mucosal regeneration persist. Relevant literature was identified through a nonsystematic search of PubMed and Ichushi-Web, using the keywords "dacryoendoscopy," "nasolacrimal duct," and "false passage," covering publications from 1995 to 2025.

Indexed as

Bent probe dacryoendoscopedacryoendoscopyduct lumen remnantfalse passage classificationminimally invasive lacrimal surgery

Identifiers

PMID41993663
PMCPMC13082800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.